Gene expression profiling of metastatic brain cancer

Oncology Reports

Volumn 18, Issue 2, 2007, Pages 321-328

  Zohrabian, Vahe Michael ^a   Nandu, Hari ^a   Gulati, Nicholas ^a   Khitrov, Greg ^b   Zhao, Connie ^b   Mohan, Avinash ^a   Demattia, Joseph ^a   Braun, Alex ^a   Das, Kaushik ^a   Murali, Raj ^a   Jhanwar Uniyal, Meena ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Gene expression profiling; Metastatic brain tumor; Neurofibromatosis 1; p53; Rho GTPase; Vascular endothelial growth factor

Indexed keywords

ADENOCARCINOMA; ARTICLE; BIOLOGICAL MODEL; BRAIN TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548526816     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.2.321     Document Type: Article

References (38)

1. Brem S and Panattil JG: An era of rapid advancement: diagnosis and treatment of metastatic brain cancer. Neurosurgery 57 (Suppl 5): S5-S9, 2005.
2. Fidler IJ: Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 10: 257-259, 2001.
3. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003. (Pubitemid 36068681)
4. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL and Massague J: Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524, 2005. (Pubitemid 41112921)
5. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA and Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549, 2003. (Pubitemid 36808649)
6. Arnold SM, Young AB, Munn RK, Patchell RA, Nanayakkara N and Markesbery WR: Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metallo-proteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 5: 4028-4033, 1999. (Pubitemid 30013780)
7. Schlegel U, Rosenfeld MR, Volkenandt M, Rosenblum M, Dalmau J and Furneaux H: p53 gene mutations in primary lung tumors are conserved in brain metastases. J Neurooncol 14: 93-100, 1992.
8. Troy CM and Shelanski ML: Caspase-2 redux. Cell Death Differ 10: 101-107, 2003. (Pubitemid 36511835)
9. Ridley AJ and Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399, 1992.
10. Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M and Dosaka-Akita H: E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small cell lung cancer cells. Cancer Res 65: 10776-10782, 2005. (Pubitemid 41713346)
11. Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR and Symons M: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24: 7821-7829, 2005. (Pubitemid 41715188)
12. Frisch SM, Vuori K, Ruoslahti E and Chan-Hui PY: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799, 1996. (Pubitemid 26269148)
13. Richardson A and Parsons T: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 380: 538-540, 1996.
14. Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti MP, Segall JD, Condeelis J, Joyce D, Minden A, Der CJ, Chan A, Symons M and Pestell RG: Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7: 816-830, 2001. (Pubitemid 34175305)
15. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF and Nelson SF: Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22: 2361- 2373, 2003.
16. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P and Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-223, 1996.
17. Xue C, Liang F, Mahmood R, Vuolo M, Wyckoff J, Qian H, Tsai KL, Kim M, Locker J, Zhang ZY and Segall JE: ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 66: 1418-1426, 2006. (Pubitemid 43259922)
18. Muller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwable J, Plewka S, Thomas M, Metzger R, Schneider PM, Brandts CH, Berdel WE and Serve H: Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 65: 1778-1782, 2005. (Pubitemid 40478604)
19. Bernards A: Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs. Biochim Biophys Acta 1242: 43-59, 1995.
20. Cichowski K and Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593-604, 2001. (Pubitemid 32201953)
21. Ozawa T, Araki N, Yunoue S, Tokuo H, Feng L, Patrakitkomjorn S, Hara T, Ichikawa Y, Matsumoto K, Fujii K and Saya H: The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J Biol Chem 280: 39524-39533, 2005. (Pubitemid 41713911)
22. Feng L, Yunoue S, Tokuo H, Ozawa T, Zhang D, Patrakitkomjorn S, Ichimura T, Saya H and Araki N: PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin. FEBS Lett 557: 275-282, 2004. (Pubitemid 38115909)
23. Corral T, Jimenez M, Hernandez-Munoz I, Perez DC I and Pellicer A: NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity. J Cell Physiol 197: 214-224, 2003. (Pubitemid 37485250)
24. Ludwig HC, Akhavan-Shigari R, Rausch S, Schallock K, Quentin C, Bockermann V and Kolenda H: Expression of focal adhesion kinase (p125 FAK) and proline-rich tyrosine kinase 2 (PYK2/CAKb) in cerebral metastases, correlation with VEGF-R-, ecNOS III-labelling and morphometric data. Anticancer Res 20: 1419-1424, 2000. (Pubitemid 30628145)
25. Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD and Cheng SY: Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66: 775-783, 2006. (Pubitemid 43165942)
26. Scian MJ, Stagliano KE, Anderson MA, Hassan S, Bowman M, Miles MF, Deb SP and Deb S: Tumor-derived p53 mutants induce NF-kappaB2 gene expression. Mol Cell Biol 25: 10097-10110, 2005. (Pubitemid 41572755)
27. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merville MP and Bours V: NF-kappa B2/p100 induces Bcl-2 expression. Leukemia 17: 1349-1356, 2003. (Pubitemid 36857343)
28. Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC and Spelsberg TC: Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res Treat 86: 75-88, 2004. (Pubitemid 38918898)
29. Tatenhorst L, Senner V, Puttmann S and Paulus W: Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 63: 210-222, 2004. (Pubitemid 38327941)
30. Zhao H, Jhanwar-Uniyal M, Datta PK, Yemul S, Ho L, Khitrov G, Kupershmidt I, Pasinetti GM, Ray T, Athwal RS and Achary MP: Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. Int J Cancer 109: 65-70, 2004. (Pubitemid 38160663)
31. Kim LS, Huang S, Lu W, Lev DC and Price JE: Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 21: 107-118, 2004. (Pubitemid 38988084)
32. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K and Eriksson U: Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95: 11709-11714, 1998. (Pubitemid 28460479)
33. Luttun A, Tjwa M and Carmeliet P: Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann NY Acad Sci 979: 80-93, 2002. (Pubitemid 36121141)
34. Sun Y, Jin K, Childs JT, Xie L, Mao XO and Greenberg DA: Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 289: 329-335, 2006. (Pubitemid 43049936)
35. Woo IS, Park MJ, Byun JH, Hong YS, Lee KS, Park YS, Lee JA, Park YI and Ahn HK: Expression of placental growth factor gene in lung cancer. Tumour Biol 25: 1-6, 2004. (Pubitemid 38822764)
36. Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashita J and Yamamoto H: Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40: 123-130, 1998. (Pubitemid 29010165)
37. Hatanaka H, Oshika Y, Abe Y, Yoshida Y, Hashimoto T, Handa A, Kijima H, Yamazaki H, Inoue H, Ueyama Y and Nakamura M: Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). Int J Mol Med 5: 181-183, 2000.
38. Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R and Bergh J: The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res 61: 2256-2260, 2001. (Pubitemid 32692056)